Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $12.20 HKD
Change Today +0.06 / 0.49%
Volume 307.5K
963 On Other Exchanges
Hong Kong
As of 4:01 AM 10/6/15 All times are local (Market data is delayed by at least 15 minutes).

bloomage biotechnology (963) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/9/15 - $20.95
52 Week Low
07/8/15 - $9.60
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BLOOMAGE BIOTECHNOLOGY (963)

Related News

No related news articles were found.

bloomage biotechnology (963) Related Businessweek News

No Related Businessweek News Found

bloomage biotechnology (963) Details

Bloomage BioTechnology Corporation Limited, an investment holding company, develops, manufactures, and sells bio-chemical products. It produces and sells hyaluronic acid (HA) raw materials used in pharmaceutical, cosmetic, and healthcare products. The company’s HA end products comprise hyaluronan soft tissue filling gel and medical sodium hyaluronate gel for ophthalmologic use, as well as bone products for intra-articular injection. It also develops, distributes, and sells medical devices, as well as sells beauty products. Bloomage BioTechnology Corporation Limited sells its products primarily in the People’s Republic of China, Asia, and the Americas. The company was founded in 2003 and is based in Jinan, the People’s Republic of China.

587 Employees
Last Reported Date: 09/17/15
Founded in 2003

bloomage biotechnology (963) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: CNY3.8M
Executive Director and Member of Nomination C...
Total Annual Compensation: CNY751.0K
Executive Director
Total Annual Compensation: CNY438.0K
Compensation as of Fiscal Year 2014.

bloomage biotechnology (963) Key Developments

Bloomage BioTechnology Corporation Limited Announces Unaudited Consolidated Cash Flow Results for the Six Months Ended June 30, 2015

Bloomage BioTechnology Corporation Limited announced unaudited consolidated cash flow results for the six months ended June 30, 2015. For the month, the company reported net cash generated from operating activities of RMB 72,500,000 compared to RMB 62,670,000 a year ago. Payment for purchase of property, plant and equipment, construction in progress and intangible assets was RMB 43,869,000 compared to RMB 88,055,000 a year ago.

Bloomage BioTechnology Corporation Limited Announces Unaudited Consolidated Financial Results for the Six Months Ended June 30, 2015

Bloomage BioTechnology Corporation Limited announced unaudited consolidated financial results for the six months ended June 30, 2015. For the six months, the company reported revenue of RMB 312,002,000 against RMB 243,847,000 a year ago. Profit from operations was RMB 131,487,000 against RMB 109,016,000 a year ago. Profit before taxation was RMB 127,260,000 against RMB 103,954,000 a year ago. Profit attributable to equity holders of the company was RMB 99,688,000 or RMB 0.292 per diluted share against RMB 83,764,000 or RMB 0.242 per diluted share a year ago. The increase in revenue was mainly attributable to the increase in sales of cosmetic grade HA raw materials and HA end products. As at 30 June 2015, the capital commitment for construction of property, plant and equipment of the group was approximately RMB 1.364 million against approximately RMB 6.190 million as on 31 December 2014.

Bloomage BioTechnology Corporation Limited to Report First Half, 2015 Results on Aug 26, 2015

Bloomage BioTechnology Corporation Limited announced that they will report first half, 2015 results on Aug 26, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
963:HK $12.20 HKD +0.06

963 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 963.
View Industry Companies

Industry Analysis


Industry Average

Valuation 963 Industry Range
Price/Earnings 18.6x
Price/Sales 5.9x
Price/Book 3.8x
Price/Cash Flow 18.2x
TEV/Sales 4.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BLOOMAGE BIOTECHNOLOGY, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at